𩺠å
§ç§å°ç§èåç
ð äžé éé»
- 22E 匷調ïŒHELP programãICU delirium prevention bundle (ABCDEF)
- Long-term cognitive sequelae of delirium èªå¯
- Dexmedetomidine in ICU sedation æžå° delirium
- TaiwanïŒgeriatric service expansion
ð§ é²éæ©èœ
- Cholinergic deficiency
- Inflammation (IL-6, CRP, TNF)
- Stress response (cortisol)
- Neurotransmitter imbalance (DA, glutamate, GABA)
- Disrupted sleep / circadian
ð é²éæ²»ç
ABCDEF Bundle (ICU)
- Assess pain
- Both SAT (spontaneous awakening trial) + SBT (spontaneous breathing trial)
- Choice of analgesia/sedationïŒdexmedetomidine > BZDïŒ
- Delirium monitoring
- Early mobility
- Family engagement
Antipsychotic Evidence
- Haloperidol: traditional first-line, but RCTs show no mortality benefit
- Quetiapine: better tolerated
- Avoid prolonged useïŒQT, EPS, fall riskïŒ
Long-term Cognitive Outcomes
- Delirium associated with persistent cognitive decline
- ICU delirium â 50% have cognitive impairment 1 year later
ð Pearls (8)
- Hypoactive æŒèšºçæé«
- Delirium æ¯ mortality marker
- Dexmedetomidine > propofol > BZD for sedation in ICU
- Music therapy æ evidence
- Family engagement éèŠ
- PD/Lewy çš quetiapine
- Long-term cognitive sequelae ç寊ååš
- æéèŠ = é é² > æ²»ç
ð ç¹æ®æ
å¢
- Post-op deliriumïŒhip surgery, cardiac surgeryïŒ
- Cancer (paraneoplastic, brain mets, opioid)
- HIV
- ESRD (dialysis disequilibrium, uremic encephalopathy)
- Cirrhosis (hepatic encephalopathy)
ð å°ç£ Context
- å¥ä¿ geriatric assessment
- HELP program emerging
- ICU sedation guidelines
- äžæ CAM å·² validated
â ïž èéå°é·
- Hypoactive æŒ
- BZD for non-withdrawal
- Glucose before thiamine
- Restraint primary
- PD/Lewy 絊 haloperidol
- ICU çš BZD sedation routine
- äžè©äŒ° polypharmacy
ð å
§å°éé»
- CAM
- DELIRIUMS
- Treatment hierarchy
- Alcohol withdrawal
- ICU bundle (ABCDEF)
- Long-term sequelae
è·šç« ç¯
- Ch 30 Coma
- Ch 31 Dementia
- Ch 466 Substance use
ð 玢åŒ
â ïž AI èçš¿ã